Literature DB >> 20152318

Percutaneous transesophageal gastrostomy tube placement: an alternative to percutaneous endoscopic gastrostomy in patients with intra-abdominal metastasis.

Ashwani Kumar Singal1, Alexander A Dekovich, Alda L Tam, Michael J Wallace.   

Abstract

BACKGROUND: PEG/jejunostomy (PEG/J) is often placed in patients with metastatic gastric cancer for palliating bowel obstruction or for feeding. However, PEG/J placement may not always be possible for many reasons.
OBJECTIVE: We wish to bring attention to the percutaneous transesophageal gastrostomy/jejunostomy (PTEG/J) as a viable alternative to nasogastric decompression in patients who are not candidates for PEG/J. PTEG/J is a largely unknown technique in the United States that designed to gain access to the stomach and proximal small bowel in these patients. We describe the use of PTEG/J in 3 patients with metastatic gastric cancer by using resources and techniques readily available in a well-stocked interventional radiology suite. PATIENTS: In the first case, percutaneous transesophageal gastrostomy (PTEG) was placed for palliation of intractable nausea and vomiting in a 37-year-woman with diffuse gastric cancer and peritoneal carcinomatosis. In the second case, PTEG was extended into the jejunum for feeding a 60-year-old woman with metastatic gastric cancer. In the third case, PTEG extending into the jejunum was placed in a 69-year-old man for palliation of bowel obstruction caused by metastatic gastric cancer and peritoneal carcinomatosis.
METHODS: After adequate sedation is administered, a 22 x 4-mm balloon catheter is passed into the esophagus over a guidewire just below the thoracic inlet. The balloon is ruptured with a needle passed through the neck under US guidance. A guidewire is then passed through the needle into the balloon and carried into the stomach or proximal small bowel by advancing the balloon catheter. The track is then dilated over the guidewire and a pigtail 45-cm-long 14F nephrostomy tube then passed into the stomach or into the proximal small bowel over the guidewire. The catheter is secured by suturing to the skin of the neck.
RESULTS: PTEG/J was effective in achieving palliation or feeding in our patients. No complications occurred.
CONCLUSIONS: PTEG/J is a safe and effective alternative to standard percutaneous gastrostomy/jejunostomy tube placement for decompression of bowel obstruction or feeding in appropriately selected patients.

Entities:  

Mesh:

Year:  2010        PMID: 20152318     DOI: 10.1016/j.gie.2009.10.037

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  5 in total

1.  The society for gastrointestinal intervention. Are we, as an organization of disparate disciplines, cooperative or competitive?

Authors:  Richard A Kozarek
Journal:  Gut Liver       Date:  2010-09-10       Impact factor: 4.519

Review 2.  Malignant Bowel Obstruction Management Over Time: Are We Doing Anything New? A Current Narrative Review.

Authors:  Farhana Shariff; Jessica Bogach; Keegan Guidolin; Ashlie Nadler
Journal:  Ann Surg Oncol       Date:  2021-10-18       Impact factor: 5.344

Review 3.  Gastrostomy tubes: Fundamentals, periprocedural considerations, and best practices.

Authors:  Anand Rajan; Peerapol Wangrattanapranee; Jonathan Kessler; Trilokesh Dey Kidambi; James H Tabibian
Journal:  World J Gastrointest Surg       Date:  2022-04-27

4.  Safety and efficacy of percutaneous transabdominal and transesophageal decompression gastric catheters for palliation of malignant bowel obstruction.

Authors:  Robert J Litwin; Alda L Tam; Rahul A Sheth; Steven M Yevich; Johanna L Chan; Amir A Jazaeri; Josiah K Halm; Sanjay Gupta; Steven Y Huang
Journal:  Abdom Radiol (NY)       Date:  2021-05-17

5.  Percutaneous transesophageal gastro-tubing (PTEG) as an alternative long-term tube feeding procedure when gastrostomy is not feasible.

Authors:  Ezekiel Wong Toh Yoon; Kazuki Nishihara
Journal:  Therap Adv Gastroenterol       Date:  2017-09-20       Impact factor: 4.409

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.